{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:47:52Z","timestamp":1785754072992,"version":"3.56.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Patients with rheumatoid arthritis (RA) are at an increased risk of developing heart failure (HF); however, the risk of readmission due to HF in patients with RA remains unclear. This study aimed to identify the risk of HF readmission among patients with RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included patients with RA aged \u226518\u00a0years who were hospitalized for the first time with HF and discharged between January 2012 and December 2019. The incidence of 90-day HF readmission was assessed. We reported the risk factors for HF readmission using the Fine\u2013Gray model as adjusted subdistribution hazard ratios (aSHRs) and 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis included 1274 patients (mean age, 76.4\u00a0years; 61.5% female; mean Charlson Comorbidity Index, 4.6). There were 146 (11.5%) cases of 90-day HF readmission, associated with the Charlson Comorbidity Index (aSHR: 1.08, 95% CI: 1.01\u20131.15), diuretic use (aSHR: 1.48, 95% CI: 1.03\u20132.13), and opioid use (aSHR: 1.76, 95% CI: 1.11\u20132.77).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with RA appeared to have a higher incidence of 90-day HF readmission than the general HF registry population. HF readmission was associated with high Charlson Comorbidity Index scores and the use of diuretics and opioids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/mr\/roag040","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:01:27Z","timestamp":1778760087000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk of 90-day readmission for heart failure among patients with rheumatoid arthritis: A retrospective cohort study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3822-6067","authenticated-orcid":false,"given":"Takano","family":"Toshio","sequence":"first","affiliation":[{"name":"Graduate School of Health and Social Services, Saitama Prefectural University, Koshigaya , Saitama ,","place":["Japan"]},{"name":"Department of Medical Affairs, Ayumi Pharmaceutical Corporation , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamada","family":"Keiko","sequence":"additional","affiliation":[{"name":"Center for University-wide Education, School of Health and Social Services, Saitama Prefectural University , Saitama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishida","family":"Ryo","sequence":"additional","affiliation":[{"name":"Department of Management, Clinical Research Center, Kurashiki Central Hospital, Kurashiki , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshima","family":"Taro","sequence":"additional","affiliation":[{"name":"Center for University-wide Education, School of Health and Social Services, Saitama Prefectural University , Saitama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"2026080306212817200_ref1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res"},{"key":"2026080306212817200_ref2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","article-title":"Cardiorheumatology: cardiac involvement in systemic rheumatic disease","volume":"12","author":"Prasad","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026080306212817200_ref3","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure - digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"2026080306212817200_ref4","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1002\/ehf2.12947","article-title":"Incidence of congestive heart failure in rheumatoid arthritis: a review of literature and meta-regression analysis","volume":"7","author":"Khalid","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026080306212817200_ref5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40801-022-00315-5","article-title":"Burden of repeated hospitalizations on patients with heart failure: an analysis of administrative and claims data in Japan","volume":"9","author":"Eguchi","year":"2022","journal-title":"Drugs Real World Outcomes"},{"key":"2026080306212817200_ref6","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1097\/MJT.0000000000000794","article-title":"The vulnerable phase of heart failure","volume":"25","author":"Gracia","year":"2018","journal-title":"Am J Ther"},{"key":"2026080306212817200_ref7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1253\/circj.CJ-19-0620","article-title":"Incidence and clinical significance of 30-day and 90-day rehospitalization for heart failure among patients with acute decompensated heart failure in Japan \u2013 from the NARA-HF study","volume":"84","author":"Ishihara","year":"2020","journal-title":"Circ J"},{"key":"2026080306212817200_ref8","doi-asserted-by":"publisher","first-page":"e32953","DOI":"10.1097\/MD.0000000000032953","article-title":"The Charlson Comorbidity Index and short-term readmission in patients with heart failure: a retrospective cohort study","volume":"102","author":"Wei","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2026080306212817200_ref9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026080306212817200_ref10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/clc.23532","article-title":"Predicting 90 day acute heart failure readmission and death using machine learning-supported decision analysis","volume":"44","author":"Sarijaloo","year":"2021","journal-title":"Clin Cardiol"},{"key":"2026080306212817200_ref11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ahj.2008.02.025","article-title":"Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis","volume":"156","author":"Setoguchi","year":"2008","journal-title":"Am Heart J"},{"key":"2026080306212817200_ref12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.23281","article-title":"Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?","volume":"58","author":"Listing","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026080306212817200_ref13","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"2026080306212817200_ref14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0167-5273(02)00470-9","article-title":"How to RECOVER from renaissance? The significance of the results of RECOVER, renaissance, RENEWAL and ATTACH","volume":"86","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"key":"2026080306212817200_ref15","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"2026080306212817200_ref16","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/bmj.330.7504.1370","article-title":"Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study","volume":"330","author":"Hudson","year":"2005","journal-title":"BMJ"},{"key":"2026080306212817200_ref17","doi-asserted-by":"publisher","first-page":"102636","DOI":"10.1016\/j.dsx.2022.102636","article-title":"Clinical outcomes of opioid administration in acute and chronic heart failure: a meta-analysis","volume":"16","author":"Pratama","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"2026080306212817200_ref18","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1136\/annrheumdis-2021-220577","article-title":"Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis","volume":"80","author":"Ocon","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026080306212817200_ref19","author":"Japanese Society for Pharmacoepidemiology, Medical and Healthcare Database Utilization Committee"},{"key":"2026080306212817200_ref20","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2147\/COPD.S386965","article-title":"Association between empirical anti-pseudomonal antibiotics for recurrent lower respiratory tract infections and mortality: a retrospective cohort study","volume":"17","author":"Shiroshita","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026080306212817200_ref21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.37737\/ace.24009","article-title":"A new electronic medical record database linked to claims data and discharge abstract data (the RWD database) in Japan: study design and profile","volume":"6","author":"Okumura","year":"2024","journal-title":"Ann Clin Epidemiol"},{"key":"2026080306212817200_ref22","volume-title":"International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), Version:2019","author":"World Health Organization","year":"2019"},{"key":"2026080306212817200_ref23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026080306212817200_ref24","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.3390\/medicina59101878","article-title":"Elderly-onset rheumatoid arthritis: characteristics and treatment options","volume":"59","author":"Pavlov-Dolijanovic","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"2026080306212817200_ref25","volume-title":"Guidelines for ATC Classification and DDD Assignment","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2024","edition":"27th"},{"key":"2026080306212817200_ref26","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2026080306212817200_ref27","doi-asserted-by":"crossref","first-page":"152727","DOI":"10.1016\/j.semarthrit.2025.152727","article-title":"Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure","volume":"73","author":"Chandrupatla","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"2026080306212817200_ref28","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080306212817200_ref29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"2026080306212817200_ref30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.26599\/1671-5411.2023.07.002","article-title":"Prevalence and clinical implications of polypharmacy and potentially inappropriate medication in elderly patients with heart failure: results of six months' follow-up","volume":"20","author":"Li","year":"2023","journal-title":"J Geriatr Cardiol"},{"key":"2026080306212817200_ref31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ejhf.462","article-title":"Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction","volume":"18","author":"Damman","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026080306212817200_ref32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/hrt.57.1.17","article-title":"Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics","volume":"57","author":"Bayliss","year":"1987","journal-title":"Br Heart J"},{"key":"2026080306212817200_ref33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/s1388-9842(02)00158-7","article-title":"Morphine for the relief of breathlessness in patients with chronic heart failure\u2014a pilot study","volume":"4","author":"Johnson","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2026080306212817200_ref34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/heart.89.9.1085","article-title":"Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure","volume":"89","author":"Williams","year":"2003","journal-title":"Heart"},{"key":"2026080306212817200_ref35","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/rheumatology\/key208","article-title":"The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatol"},{"key":"2026080306212817200_ref36","doi-asserted-by":"publisher","first-page":"e014240","DOI":"10.1161\/JAHA.119.014240","article-title":"Clinical implications of the New York Heart Association classification","volume":"8","author":"Caraballo","year":"2019","journal-title":"J Am Heart Assoc"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roag040\/68293425\/roag040.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roag040\/68293425\/roag040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:21:36Z","timestamp":1785752496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/advance-article\/doi\/10.1093\/mr\/roag040\/8678959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1093\/mr\/roag040","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"roag040"}}